Vcanbio Cell & Gene Engineering Corp Ltd (600645) — Cash Flow Reinvestment Rate
Vcanbio Cell & Gene Engineering Corp Ltd (600645) has a Cash Flow Reinvestment Rate of 0.13x as of September 2025, reinvesting CN¥13.28 Million (capex CN¥13.28 Million ) from operating cash flow of CN¥103.70 Million. Explore 600645 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Vcanbio Cell & Gene Engineering Corp Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Vcanbio Cell & Gene Engineering Corp Ltd across 25 annual periods. Also explore Vcanbio Cell & Gene Engineering Corp Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Vcanbio Cell & Gene Engineering Corp Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Vcanbio Cell & Gene Engineering Corp Ltd. For live market cap and broader valuation context, see market cap of Vcanbio Cell & Gene Engineering Corp Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.39x | CN¥748.16 Million | CN¥313.63 Million | CN¥49.56 Million | ▲ +872.0% |
| 2024 | 0.25x | CN¥69.99 Million | CN¥285.19 Million | CN¥67.32 Million | ▼ -59.0% |
| 2023 | 0.60x | CN¥179.11 Million | CN¥299.02 Million | CN¥88.61 Million | ▼ -20.6% |
| 2022 | 0.75x | CN¥197.53 Million | CN¥261.89 Million | CN¥99.19 Million | ▲ +65.0% |
| 2021 | 0.46x | CN¥146.69 Million | CN¥320.96 Million | CN¥127.74 Million | ▼ -76.3% |
| 2020 | 1.93x | CN¥471.61 Million | CN¥244.35 Million | CN¥91.72 Million | ▼ -17.5% |
| 2019 | 2.34x | CN¥564.98 Million | CN¥241.49 Million | CN¥122.95 Million | ▲ +80.1% |
| 2018 | 1.30x | CN¥168.98 Million | CN¥130.08 Million | CN¥128.13 Million | ▼ -48.4% |
| 2017 | 2.52x | CN¥176.96 Million | CN¥70.27 Million | CN¥83.02 Million | ▼ -32.9% |
| 2016 | 3.75x | CN¥538.92 Million | CN¥143.67 Million | CN¥269.85 Million | ▼ -90.8% |
| 2015 | 40.66x | CN¥332.43 Million | CN¥8.17 Million | CN¥128.70 Million | ▲ +14791.4% |
| 2014 | 0.27x | CN¥60.47 Million | CN¥221.45 Million | CN¥60.47 Million | ▼ -57.1% |
| 2013 | 0.64x | CN¥70.43 Million | CN¥110.72 Million | CN¥70.43 Million | ▼ -19.4% |
| 2012 | 0.79x | CN¥55.56 Million | CN¥70.41 Million | CN¥55.56 Million | ▲ +488.4% |
| 2011 | 0.13x | CN¥14.81 Million | CN¥110.44 Million | CN¥14.81 Million | ▲ +352.1% |
| 2010 | 0.03x | CN¥5.22 Million | CN¥175.93 Million | CN¥5.22 Million | ▼ -78.6% |
| 2009 | 0.14x | CN¥17.32 Million | CN¥124.92 Million | CN¥17.32 Million | ▼ -17.0% |
| 2008 | 0.17x | CN¥20.32 Million | CN¥121.60 Million | CN¥20.32 Million | ▲ +4.1% |
| 2007 | 0.16x | CN¥17.92 Million | CN¥111.68 Million | CN¥17.92 Million | ▼ -74.4% |
| 2006 | 0.63x | CN¥47.67 Million | CN¥76.12 Million | CN¥47.67 Million | ▼ -7.8% |
| 2005 | 0.68x | CN¥57.55 Million | CN¥84.69 Million | CN¥57.55 Million | ▲ +44.2% |
| 2004 | 0.47x | CN¥27.23 Million | CN¥57.76 Million | CN¥27.23 Million | ▼ -45.5% |
| 2003 | 0.86x | CN¥36.08 Million | CN¥41.74 Million | CN¥36.08 Million | ▲ +219.3% |
| 2000 | 0.27x | CN¥8.58 Million | CN¥31.71 Million | CN¥8.58 Million | ▼ -87.2% |
| 1999 | 2.12x | CN¥8.76 Million | CN¥4.13 Million | CN¥8.76 Million | — |